PentaOmix

Shedding Light on Cancer - Diagnosing cancer better and faster using hyperspectral data & AI

Health Tech & Life Sciences
Active
Pre-Funding Rehovot, Israel Founded 2020
Last updated 2026-06-18
Total raised
$2.3M
Last: Grant 2022-02
Stage
Pre-Funding
Founded
2020
Headcount
5
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

Pentaomix is developing a novel modality for digital pathology that aims to revolutionize the ability of doctors to match each cancer patient with the right drug. The companys system is based on hyperspectral imaging and AI algorithms to enable a deeper understanding of the tumors microenvironment and a holistic viewpoint of the tumor progression. The Pentaomix system will enable a shorter development time for cancer drug biomarkers and improved screening for clinical studies, and will eventually serve as a companion diagnostic in hospitals.

Funding history · 1 round · $2.3M total

2022-02
Grant $2.3M

Q&A

What is PentaOmix's primary focus?
PentaOmix is developing a novel modality for digital pathology that uses hyperspectral imaging and AI algorithms to improve cancer diagnosis and drug matching for patients.
When was PentaOmix founded?
PentaOmix was founded in July 2020.
What is PentaOmix's total funding to date?
PentaOmix has raised a total of $2,275,000 USD.
When was PentaOmix's last funding round and who were the lead investors?
PentaOmix's last funding round was a Grant in February 2022, with ATTRACT Project as the lead investor.
Who are the co-founders of PentaOmix?
The co-founders of PentaOmix are Boaz Brill (Co-founder & CEO) and Yuval Garini (Co-founder & CSO).
In which country is PentaOmix headquartered?
PentaOmix is headquartered in Rehovot, Israel.
What technologies does PentaOmix utilize in its solutions?
PentaOmix utilizes Artificial Intelligence, Computer Vision, Image Recognition, Deep Learning, Sensing, and Chromatics & Light in its solutions.

Team · 2

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CSO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceComputer VisionImage RecognitionDeep LearningSensingChromatics & Light
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersLaboratoriesMedical Devices IndustryMedical Equipment
Business model
B2B

Highlights

1 PatentsVerified

Tags

decision-supportoncologyhospitalscancerdiagnosticsdigital-healthcarehealthcare-providersimagingdoctorsalgorithmsbiopsypharma-companiesdrug-developmentprecision-medicineartificial-intelligence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)